Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Adoptive Cellular Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Kite Pharma Inc
Celularity Inc
Nkarta Inc
NantKwest Inc
bluebird bio Inc
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Bellicum Pharmaceuticals Inc
Celyad SA
Beijing Immunochina Medical Science & Technology Co Ltd
Bristol-Myers Squibb Co
Sorrento Therapeutics Inc
Daiichi Sankyo Co Ltd
Autolus Therapeutics Plc
Amgen Inc
Cell Medica Ltd
Hangzhou Converd Co Ltd
Gilead Sciences Inc
Juno Therapeutics Inc
Ono Pharmaceutical Co Ltd
Celgene Corp
Fosun Pharmaceutical AG
Cellular Biomedicine Group Inc
Nanjing Legend Biotech Co Ltd
Novartis AG
Guangzhou Anjie Biomedical Technology Co Ltd
Takara Bio Inc
CARsgen Therapeutics Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other
Application:
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Adoptive Cellular Immunotherapy Industry Overview
-
1.1.1 Adoptive Cellular Immunotherapy Market Scope and Market Segments
-
1.1.2 Adoptive Cellular Immunotherapy Industry Characteristics
-
1.1.3 Global and China Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Adoptive Cellular Immunotherapy Production Value and Growth Rate (2017-2028)
-
1.2 Global Adoptive Cellular Immunotherapy Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 TIL
-
1.2.2 LAK
-
1.2.3 CAR-T
-
1.2.4 TCR-T
-
1.2.5 CIK
-
1.2.6 NK
-
1.2.7 DC
-
1.2.8 Other
-
1.3 Global Adoptive Cellular Immunotherapy Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Cancer Hospital
-
1.3.3 Centers for Disease Control and Prevention
-
1.3.4 Rehabilitation Center
-
1.3.5 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Adoptive Cellular Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Adoptive Cellular Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Adoptive Cellular Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Adoptive Cellular Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Adoptive Cellular Immunotherapy Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Adoptive Cellular Immunotherapy Industry Porter's Five Forces Model Analysis
-
2.2.3 Adoptive Cellular Immunotherapy Industry PEST Analysis
-
2.3 Adoptive Cellular Immunotherapy Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Adoptive Cellular Immunotherapy Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Adoptive Cellular Immunotherapy Industry
Chapter 3 Global and China Adoptive Cellular Immunotherapy Market, by Manufacturer
-
3.1 Global and China Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Adoptive Cellular Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Adoptive Cellular Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Adoptive Cellular Immunotherapy Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Adoptive Cellular Immunotherapy Market Top 3 Players
Chapter 4 Global and China Adoptive Cellular Immunotherapy Market, by Type (2017-2028)
-
4.1 Adoptive Cellular Immunotherapy Market Trend, by Type
-
4.2 Global Adoptive Cellular Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Adoptive Cellular Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Adoptive Cellular Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Adoptive Cellular Immunotherapy Price Trend, by Type (2017-2028)
-
4.3 China Adoptive Cellular Immunotherapy Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Adoptive Cellular Immunotherapy Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Adoptive Cellular Immunotherapy Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Adoptive Cellular Immunotherapy Price Trend, by Type (2017-2028)
Chapter 5 Global and China Adoptive Cellular Immunotherapy Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Adoptive Cellular Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Adoptive Cellular Immunotherapy Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Adoptive Cellular Immunotherapy Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Adoptive Cellular Immunotherapy Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Adoptive Cellular Immunotherapy Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Adoptive Cellular Immunotherapy Market Analysis
-
7.1 North America Adoptive Cellular Immunotherapy Market, by Type
-
7.2 North America Adoptive Cellular Immunotherapy Market, by Application
-
7.3 North America Adoptive Cellular Immunotherapy Market Analysis and Forecast, by Country
-
7.3.1 United States Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Adoptive Cellular Immunotherapy Market Analysis
-
8.1 Europe Adoptive Cellular Immunotherapy Market, by Type
-
8.2 Europe Adoptive Cellular Immunotherapy Market, by Application
-
8.3 Europe Adoptive Cellular Immunotherapy Market Analysis and Forecast, by Country
-
8.3.1 Germany Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Adoptive Cellular Immunotherapy Market Analysis
-
9.1 APAC Adoptive Cellular Immunotherapy Market, by Type
-
9.2 APAC Adoptive Cellular Immunotherapy Market, by Application
-
9.3 APAC Adoptive Cellular Immunotherapy Market Analysis and Forecast, by Country
-
9.3.1 China Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Market Analysis
-
10.1 Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Market, by Type
-
10.2 Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Market, by Application
-
10.3 Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Adoptive Cellular Immunotherapy Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Adoptive Cellular Immunotherapy Company Profiles
-
11.1 Kite Pharma Inc
-
11.1.1 Kite Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.1.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Celularity Inc
-
11.2.1 Celularity Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Celularity Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.2.3 Celularity Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Nkarta Inc
-
11.3.1 Nkarta Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Nkarta Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.3.3 Nkarta Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 NantKwest Inc
-
11.4.1 NantKwest Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 NantKwest Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.4.3 NantKwest Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 bluebird bio Inc
-
11.5.1 bluebird bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 bluebird bio Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.5.3 bluebird bio Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Hebei Senlang Biotechnology Inc Ltd
-
11.6.1 Hebei Senlang Biotechnology Inc Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.6.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 HRAIN Biotechnology Co Ltd
-
11.7.1 HRAIN Biotechnology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.7.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Bellicum Pharmaceuticals Inc
-
11.8.1 Bellicum Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.8.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Celyad SA
-
11.9.1 Celyad SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Celyad SA Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.9.3 Celyad SA Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Beijing Immunochina Medical Science & Technology Co Ltd
-
11.10.1 Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.10.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Bristol-Myers Squibb Co
-
11.11.1 Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.11.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Sorrento Therapeutics Inc
-
11.12.1 Sorrento Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.12.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Daiichi Sankyo Co Ltd
-
11.13.1 Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Autolus Therapeutics Plc
-
11.14.1 Autolus Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.14.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Amgen Inc
-
11.15.1 Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Amgen Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.15.3 Amgen Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Cell Medica Ltd
-
11.16.1 Cell Medica Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.16.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Hangzhou Converd Co Ltd
-
11.17.1 Hangzhou Converd Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Gilead Sciences Inc
-
11.18.1 Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.18.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Juno Therapeutics Inc
-
11.19.1 Juno Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.19.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.20 Ono Pharmaceutical Co Ltd
-
11.20.1 Ono Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.20.2 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.20.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.21 Celgene Corp
-
11.21.1 Celgene Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.21.2 Celgene Corp Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.21.3 Celgene Corp Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.22 Fosun Pharmaceutical AG
-
11.22.1 Fosun Pharmaceutical AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.22.2 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.22.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.23 Cellular Biomedicine Group Inc
-
11.23.1 Cellular Biomedicine Group Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.23.2 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.23.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.24 Nanjing Legend Biotech Co Ltd
-
11.24.1 Nanjing Legend Biotech Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.24.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.24.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.25 Novartis AG
-
11.25.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.25.2 Novartis AG Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.25.3 Novartis AG Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.26 Guangzhou Anjie Biomedical Technology Co Ltd
-
11.26.1 Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.26.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.26.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.27 Takara Bio Inc
-
11.27.1 Takara Bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.27.2 Takara Bio Inc Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.27.3 Takara Bio Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.28 CARsgen Therapeutics Ltd
-
11.28.1 CARsgen Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.28.2 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.28.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.29 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
-
11.29.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.29.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Profiles, Application and Specification
-
11.29.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Adoptive Cellular Immunotherapy Industry Investment Prospect and Risk Assessment
-
12.1 Adoptive Cellular Immunotherapy Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Adoptive Cellular Immunotherapy Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Production Value and Growth Rate (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of TIL (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of LAK (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of CAR-T (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of TCR-T (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of CIK (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of NK (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of DC (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of Cancer Hospital (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of Centers for Disease Control and Prevention (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of Rehabilitation Center (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Adoptive Cellular Immunotherapy Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Adoptive Cellular Immunotherapy Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Adoptive Cellular Immunotherapy Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Adoptive Cellular Immunotherapy Market Share, by Manufacturer in 2021
-
Figure Global and China Adoptive Cellular Immunotherapy Market Share, by Manufacturer in 2022
-
Table Global Adoptive Cellular Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Value, by Type (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Price Trend, by Type (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Volume, by Type (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Value, by Type (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Value Share, by Type (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Price Trend, by Type (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Value, by Application (2017-2028)
-
Table Global Adoptive Cellular Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure Global Adoptive Cellular Immunotherapy Sales Value Share, by Application (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Volume, by Application (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Value, by Application (2017-2028)
-
Table China Adoptive Cellular Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Value Share, by Application (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure North America Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Production, Import, Consumption and Export (2017-2022)
-
Table North America Adoptive Cellular Immunotherapy Sales Volume, by Type (2017-2028)
-
Table North America Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure North America Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table North America Adoptive Cellular Immunotherapy Sales Volume, by Application (2017-2028)
-
Table North America Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure North America Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure United States Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure United States Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Canada Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Europe Adoptive Cellular Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Europe Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Europe Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Europe Adoptive Cellular Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Europe Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Europe Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Germany Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure UK Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure UK Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure France Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure France Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Italy Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Spain Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Poland Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Russia Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table APAC Adoptive Cellular Immunotherapy Sales Volume, by Type (2017-2028)
-
Table APAC Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure APAC Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table APAC Adoptive Cellular Immunotherapy Sales Volume, by Application (2017-2028)
-
Table APAC Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure APAC Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure China Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Japan Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure India Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure India Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Adoptive Cellular Immunotherapy Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Adoptive Cellular Immunotherapy Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Adoptive Cellular Immunotherapy Sales Value and Growth Rate (2017-2028)
-
Table Kite Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kite Pharma Inc Product Profiles, Application and Specification
-
Table Kite Pharma Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celularity Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celularity Inc Product Profiles, Application and Specification
-
Table Celularity Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Nkarta Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Nkarta Inc Product Profiles, Application and Specification
-
Table Nkarta Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table NantKwest Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table NantKwest Inc Product Profiles, Application and Specification
-
Table NantKwest Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table bluebird bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table bluebird bio Inc Product Profiles, Application and Specification
-
Table bluebird bio Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hebei Senlang Biotechnology Inc Ltd Product Profiles, Application and Specification
-
Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table HRAIN Biotechnology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table HRAIN Biotechnology Co Ltd Product Profiles, Application and Specification
-
Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bellicum Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bellicum Pharmaceuticals Inc Product Profiles, Application and Specification
-
Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celyad SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celyad SA Product Profiles, Application and Specification
-
Table Celyad SA Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beijing Immunochina Medical Science & Technology Co Ltd Product Profiles, Application and Specification
-
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Co Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sorrento Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sorrento Therapeutics Inc Product Profiles, Application and Specification
-
Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Daiichi Sankyo Co Ltd Product Profiles, Application and Specification
-
Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Autolus Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Autolus Therapeutics Plc Product Profiles, Application and Specification
-
Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Inc Product Profiles, Application and Specification
-
Table Amgen Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cell Medica Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cell Medica Ltd Product Profiles, Application and Specification
-
Table Cell Medica Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hangzhou Converd Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hangzhou Converd Co Ltd Product Profiles, Application and Specification
-
Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Sciences Inc Product Profiles, Application and Specification
-
Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Juno Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Juno Therapeutics Inc Product Profiles, Application and Specification
-
Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ono Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ono Pharmaceutical Co Ltd Product Profiles, Application and Specification
-
Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celgene Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celgene Corp Product Profiles, Application and Specification
-
Table Celgene Corp Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Fosun Pharmaceutical AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Fosun Pharmaceutical AG Product Profiles, Application and Specification
-
Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cellular Biomedicine Group Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cellular Biomedicine Group Inc Product Profiles, Application and Specification
-
Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Nanjing Legend Biotech Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Nanjing Legend Biotech Co Ltd Product Profiles, Application and Specification
-
Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis AG Product Profiles, Application and Specification
-
Table Novartis AG Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Guangzhou Anjie Biomedical Technology Co Ltd Product Profiles, Application and Specification
-
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takara Bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takara Bio Inc Product Profiles, Application and Specification
-
Table Takara Bio Inc Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CARsgen Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CARsgen Therapeutics Ltd Product Profiles, Application and Specification
-
Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Product Profiles, Application and Specification
-
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
